3 ms·
So what I’m wondering is how people in these trials deal with the depressive effects after it wears off. Or are the dosages so low it doesn’t matter? I see no m
by spacemadness 3y ago
So what I’m wondering is how people in these trials deal with the depressive effects after it wears off. Or are the dosages so low it doesn’t matter? I see no mention of this in the article.
- zealtrace 3y agoThis is covered in the actual studies, which are quite readable if you're curious. The metric of concern is suicide attempts, and the rate is about the same between placebo and control groups. Long term followup data will be informative, particularly as they attempt to scale up the treatment. Depressive effects aren't typically the greatest concern with this population. The risk to manage is traumatic material and sensations coming on more strongly afterward and overwhelming the person's capacity to regulate. This is one of the reasons the trauma informed psychotherapy aspect of the treatment is important.